Nanomedicine for the Management of Pulmonary Disorders

Authored by: Pompy Patowary , Manash Pratim Pathak , Pronobesh Chattopadhyay , Kamaruz Zaman

Handbook of Lung Targeted Drug Delivery Systems

Print publication date:  October  2021
Online publication date:  October  2021

Print ISBN: 9780367490676
eBook ISBN: 9781003046547
Adobe ISBN:


 Download Chapter



Since the early 2000s, nanomedicine has emerged as a fascinating interdisciplinary field of research based on the use of nanoscale materials or devices for diagnosis and drug delivery as well as therapeutic methods for the development of nanopharmaceuticals. Respiratory diseases make up 5 of the 30 most common causes of death and the numbers are likely to increase in the near future. In recent years, nanomedicine has gained immense popularity for the targeted delivery of therapeutic and diagnostic compounds to the lungs, and a number of respiratory diseases have been approached using nanomedicines like solid-lipid nanoparticles (SLN), liposomes, dendrimers, micelles, nanotubes, and nanocarriers. However, the biodegradability and toxicity of the polymers for long-term use should be closely examined in the formulation of polymeric NPs for pulmonary delivery. Also, from a safety perspective, the need to connect several major themes, viz. safety, regulation, research quality, and innovation of current respiratory nanotoxicology, are apparent.

Search for more...
Back to top

Use of cookies on this website

We are using cookies to provide statistics that help us give you the best experience of our site. You can find out more in our Privacy Policy. By continuing to use the site you are agreeing to our use of cookies.